# BLINCYTO

NDC: 55513-160
Generic name: blinatumomab
Labeler / Manufacturer: Amgen, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20141218

FDA application: BLA125557

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-160"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-160
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=38b482a8-960b-4591-9857-5031ecb830aa